Suppr超能文献

一位 65 岁男性,因术后下肢深静脉血栓形成行利伐沙班预防治疗后出现双侧肾上腺出血。

A 65-Year-Old Man with Bilateral Adrenal Hemorrhage Following Prophylaxis for Postoperative Deep Vein Thrombosis with Rivaroxaban.

机构信息

Department of Pharmacy, Al Wakrah Hospital, Hamad Medical Corporation, Doha, Qatar.

Department of Internal Medicine, Al Wakrah Hospital, Hamad Medical Corporation, Doha, Qatar.

出版信息

Am J Case Rep. 2023 Sep 2;24:e939816. doi: 10.12659/AJCR.939816.

Abstract

BACKGROUND Direct oral anticoagulant (DOAC) agents, such as rivaroxaban, treat and prevent venous thrombosis. Although adrenal hemorrhage due to DOACs has previously been reported, this is a rare condition that can present as an emergency. In this case report, we present a 65-year-old man who recently had bilateral knee arthroplasty and was started on rivaroxaban 10 mg daily for deep vein thrombosis (DVT) prophylaxis following the surgery. CASE REPORT Ten days after bilateral knee arthroplasty and starting rivaroxaban, the patient presented to the Emergency Department with severe, sudden abdominal pain. Abdominal computed tomography detected significantly enlarged bilateral adrenals, with ill-defined heterogeneous density extending to the upper part of perinephric and paranephric spaces, suggesting bilateral adrenal hemorrhage. A cosyntropin stimulation test was used to confirm the suspicion of adrenal insufficiency. Cortisol levels were 66 nmol/L before stimulation and 83 nmol/L 60 min after cosyntropin administration. Hydrocortisone was started intravenously at a dose of 50 mg every 8 h. After his symptoms improved, he was discharged on oral hydrocortisone at 10 mg in the morning and 5 mg in the evening. Seven weeks after discharge, follow-up abdominal ultrasonography showed that the bilateral adrenal hemorrhage had resolved. CONCLUSIONS This case supports previous cases of adrenal hemorrhage as a rare but serious association with rivaroxaban and highlights the importance of rapid diagnosis using imaging and monitoring of patients for this possible adverse effect. Practitioners must remain vigilant when prescribing anticoagulation therapy, especially in patients who are at an increased risk for adrenal hemorrhage.

摘要

背景

直接口服抗凝剂(DOAC)药物,如利伐沙班,可用于治疗和预防静脉血栓形成。尽管以前有报道过 DOAC 引起的肾上腺出血,但这种情况很少见,可能表现为急症。在本病例报告中,我们报告了一位 65 岁男性,他最近接受了双侧膝关节置换术,术后开始每天服用 10 毫克利伐沙班预防深静脉血栓形成(DVT)。

病例报告

在双侧膝关节置换术后和开始使用利伐沙班的 10 天后,患者因严重、突发性腹痛到急诊科就诊。腹部计算机断层扫描发现双侧肾上腺明显增大,密度不均,延伸至肾周和肾旁间隙的上部,提示双侧肾上腺出血。使用促皮质素刺激试验证实了肾上腺功能不全的怀疑。皮质醇水平在刺激前为 66 nmol/L,在促皮质素给药后 60 分钟为 83 nmol/L。静脉给予氢化可的松,剂量为 50 mg,每 8 小时一次。在症状改善后,他开始口服氢化可的松,早上 10 毫克,晚上 5 毫克。出院后 7 周,随访腹部超声显示双侧肾上腺出血已吸收。

结论

本病例支持以前的病例报告,即肾上腺出血是利伐沙班罕见但严重的不良反应之一,强调了使用影像学快速诊断和监测患者可能出现这种不良反应的重要性。医生在开具抗凝治疗药物时必须保持警惕,特别是在那些有更高肾上腺出血风险的患者中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bbb/10479204/b6b034ac3318/amjcaserep-24-e939816-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验